MicroRNA-26b acts as an antioncogene and prognostic factor in cervical cancer

Lihong Wang1, Wen Wang1, Yuanyuan Wu1

  • 1Department of Pathology, Shangluo Central Hospital, Shangluo, Shaanxi 726000, P.R. China.

Oncology Letters
|March 15, 2019
PubMed

Insights

MicroRNA-26b (miR-26b) is downregulated in cervical cancer, inhibiting tumor cell migration and invasion. Targeting the miR-26b/Jagged1 (JAG1) axis offers a potential new treatment strategy for cervical cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cervical cancer is a leading global malignancy in women.
  • MicroRNA-26b (miR-26b) is frequently downregulated in various cancers, but its role in cervical cancer is understudied.
  • Understanding miR-26b's function is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role of miR-26b in cervical carcinoma.
  • To determine the relationship between miR-26b and Jagged1 (JAG1) in cervical cancer cells.
  • To explore the potential of the miR-26b/JAG1 axis as a therapeutic target.

Main Methods:

  • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) for gene expression analysis.
  • Transwell assays to assess cell migration and invasion.
  • Luciferase reporter assays to validate direct targeting of JAG1 by miR-26b.

Main Results:

  • miR-26b expression was significantly downregulated in cervical cancer tissues and cells compared to normal controls.
  • Reduced miR-26b expression correlated with increased cell migration and invasion.
  • JAG1 was identified as a direct target of miR-26b, with inverse expression correlation.
  • miR-26b suppressed cervical cancer cell migration and invasion by targeting JAG1, an effect partially reversed by JAG1 overexpression.

Conclusions:

  • miR-26b acts as a tumor suppressor in cervical cancer by inhibiting cell migration and invasion.
  • The miR-26b/JAG1 axis represents a promising novel therapeutic target for cervical cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Forces Acting on Chromosomes02:11

Forces Acting on Chromosomes

During mitosis, chromosome movements occur through the interplay of multiple piconewton level forces. In prometaphase, these forces help in chromosome assembly or congression at the equatorial plane, eventually leading to their alignment at the metaphase plate. The forces acting on the chromosomes are space and time-dependent; therefore, they vary with the position of the chromosomes as the cell progresses through mitosis. 
Microtubules and motor proteins exert two types of forces on...
3.9K
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.9K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.1K
Drugs Acting on Autonomic Ganglia: Blockers01:28

Drugs Acting on Autonomic Ganglia: Blockers

Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.7K